Trial Profile
Clinical Trial of NAC in Asthma
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 21 Aug 2019
Price :
$35
*
At a glance
- Drugs Acetylcysteine (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms CONA
- 17 Oct 2018 Status changed from active, no longer recruiting to discontinued.
- 11 Apr 2018 Planned End Date changed from 1 Feb 2019 to 1 Jun 2019.
- 11 Apr 2018 Planned primary completion date changed from 1 Feb 2018 to 1 Jun 2018.